Neogenomics (NEO) Non-Current Deferred Tax Liability (2013 - 2026)

Neogenomics has reported Non-Current Deferred Tax Liability for 14 years, with the latest figure at $17.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 16.79% year-over-year to $17.4 million; the trailing twelve-month figure through Mar 2026 stood at $17.4 million (down 16.79% YoY), and the FY2025 full-year result was $18.2 million, down 82.33% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $17.4 million, down from $18.2 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $129.6 million in Q4 2022, with the low at $17.4 million in Q1 2026.
• Historically, Non-Current Deferred Tax Liability has averaged $38.0 million across 5 years, with a median of $24.3 million in 2023.
• Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability soared 2864.97% — and 2025, when it sank 82.33%.
• Neogenomics' Non-Current Deferred Tax Liability stood at $129.6 million in 2022, then slumped by 81.25% to $24.3 million in 2023, then jumped by 324.58% to $103.1 million in 2024, then slumped by 82.33% to $18.2 million in 2025, then declined by 4.22% to $17.4 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $17.4 million (Q1 2026), $18.2 million (Q4 2025), and $20.8 million (Q3 2025), per Business Quant data.